A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers.
Primary erythromelalgia (PE) is an autosomal dominant neurological disorder characterized by severe burning pain and erythema in the extremities upon heat stimuli or exercise. Mutations in human SCN9A gene, encoding the α-subunit of the voltage-gated sodium channel, Na(v)1.7, were found to be respon...
Guardado en:
Autores principales: | Min-Tzu Wu, Po-Yuan Huang, Chen-Tung Yen, Chih-Cheng Chen, Ming-Jen Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e62c19f95378472db545319cf89122c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome
por: Akira Ueoka, et al.
Publicado: (2018) -
Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers
por: Kawabata M, et al.
Publicado: (2015) -
Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Hannan Safiyyah Tan Sian Hui Abdullah, et al.
Publicado: (2021) -
Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine.
por: Louisiane Lemaire, et al.
Publicado: (2021) -
[9] α-Blockers and acute urinary retention
por: Samir Bouras
Publicado: (2018)